Citalopram to Enhance Cognition in HD

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2011

Study Completion Date

November 30, 2011

Conditions
Huntington DiseaseChoreaExecutive Dysfunction
Interventions
DRUG

20mg daily citalopram

a selective serotonin reuptake inhibitor (SSRI) treatment administered over 16 weeks

DRUG

Placebo

a daily matching placebo administered over 16 weeks

Trial Locations (3)

14618

University of Rochester, Rochester

52242

The University of Iowa, Iowa City

85259

Mayo Clinic Arizona, Scottsdale

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Cure Huntington's Disease Initiative (CHDI)

UNKNOWN

collaborator

University of Rochester

OTHER

collaborator

Mayo Clinic

OTHER

lead

University of Iowa

OTHER

NCT00271596 - Citalopram to Enhance Cognition in HD | Biotech Hunter | Biotech Hunter